• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茶碱的生物利用度:茶碱酏剂和两种复方茶碱片的口服吸收与静脉注射氨茶碱的比较。

Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.

作者信息

Fixley M, Shen D D, Azarnoff D L

出版信息

Am Rev Respir Dis. 1977 Jun;115(6):955-62. doi: 10.1164/arrd.1977.115.6.955.

DOI:10.1164/arrd.1977.115.6.955
PMID:262107
Abstract

The bioavailability of theophylline from single doses of an elixir (Elixophyllin) and two different tablet formulations, as compared to intravenous aminophylline, was studied with a crossover design in 12 normal volunteers. Both tablet formulations (Marax and Tedral) contain ephedrine. Marax contains hydroxyzine hydrochloride, and Tedral contains phenobarbital. The absorption of theophylline was most rapid from the elixir, whereas that from Marax was faster than that from Tedral. The peak concentrations of theophylline after administration of the 3 oral dosage forms were in the order, elixir greater than Marax greater than Tedral, however, the time to achieve peak concentration was highly variable and did not differ significantly among the 3 products. On the basis of area under the serum concentration-time curves, the absorption of theophylline from the elixir and from Marax was essentially complete. The area under the serum concentration curve after administration of Tedral was significantly less than that after intravenous aminophylline, elixir, and Marax; however, when the individual areas under the concentration curves were adjusted for intrasubject variation in elimination rate constant, the mean area under the concentration curve after Tedral no longer differed significantly from those of the intravenous and other two oral products. A large degree of intersubject variation in the oral absorption of theophylline was observe din this study. Therefore, in addition to the well-documented, large individual variation in the serum clearance of theophylline, intersubject differences in the absorption of the drug is another factor that complicates proper adjustment of the dose in oral theophylline therapy.

摘要

采用交叉设计,在12名正常志愿者中研究了单剂量的茶碱酏剂(Elixophyllin)和两种不同片剂制剂与静脉注射氨茶碱相比的生物利用度。两种片剂制剂(Marax和Tedral)均含有麻黄碱。Marax含有盐酸羟嗪,Tedral含有苯巴比妥。茶碱从酏剂中的吸收最快,而从Marax中的吸收比从Tedral中更快。三种口服剂型给药后茶碱的峰值浓度顺序为:酏剂>Marax>Tedral,然而,达到峰值浓度的时间变化很大,三种产品之间无显著差异。根据血清浓度-时间曲线下面积,茶碱从酏剂和Marax中的吸收基本完全。Tedral给药后血清浓度曲线下面积显著小于静脉注射氨茶碱、酏剂和Marax给药后的面积;然而,当根据个体消除速率常数的变化对浓度曲线下的个体面积进行校正后,Tedral给药后浓度曲线下的平均面积与静脉注射及其他两种口服产品的不再有显著差异。本研究观察到茶碱口服吸收存在很大程度的个体间差异。因此,除了茶碱血清清除率存在充分记录的个体差异外,药物吸收的个体间差异是口服茶碱治疗中剂量合理调整复杂化的另一个因素。

相似文献

1
Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.茶碱的生物利用度:茶碱酏剂和两种复方茶碱片的口服吸收与静脉注射氨茶碱的比较。
Am Rev Respir Dis. 1977 Jun;115(6):955-62. doi: 10.1164/arrd.1977.115.6.955.
2
Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.
J Pharm Sci. 1978 Jul;67(7):916-9. doi: 10.1002/jps.2600670711.
3
Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.来自缓释氨茶碱制剂(优喘平缓释片)的茶碱生物利用度——单次和多次口服给药后的血浆水平
Int J Clin Pharmacol Ther Toxicol. 1981 May;19(5):223-7.
4
Absolute bioavailability of oral theophylline.口服茶碱的绝对生物利用度。
Am J Hosp Pharm. 1977 May;34(5):525-7.
5
Absorption of sustained-release theophylline tablets.
Int J Clin Pharmacol Ther Toxicol. 1983 Jul;21(7):359-62.
6
A multiple-dose study of sustained-release theophylline and aminophylline.缓释茶碱和氨茶碱的多剂量研究。
Chest. 1980 Aug;78(2):300-3. doi: 10.1378/chest.78.2.300.
7
The relation of product formulation to absorption of oral theophylline.产品配方与口服茶碱吸收的关系。
N Engl J Med. 1978 Oct 19;299(16):852-7. doi: 10.1056/NEJM197810192991603.
8
Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.多剂量缓释制剂和酏剂在人体中茶碱的比较吸收情况。
Clin Ther. 1982;4(6):489-96.
9
Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.茶碱加羟乙茶碱缓释片和普通片的药代动力学及其与氨茶碱片的比较。
Indian J Chest Dis Allied Sci. 1991 Jan-Mar;33(1):1-8.
10
Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.在健康男性非吸烟志愿者中,单次口服给药后片剂中奎宁和茶碱相对于静脉输注的绝对生物利用度研究。
Methods Find Exp Clin Pharmacol. 1994 Nov;16(9):651-60.

引用本文的文献

1
Pharmacokinetic drug interactions in liver disease: An update.肝病中的药代动力学药物相互作用:最新进展。
World J Gastroenterol. 2016 Jan 21;22(3):1260-78. doi: 10.3748/wjg.v22.i3.1260.
2
Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.对15种市售茶碱产品吸收情况的评估表明,当前应用的生物利用度标准存在缺陷。
J Pharmacokinet Biopharm. 1980 Jun;8(3):229-42. doi: 10.1007/BF01059644.
3
Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
阻塞性气道疾病患者的个体化氨茶碱治疗:根据静脉试验剂量预测口服剂量
Eur J Clin Pharmacol. 1982;23(2):111-21. doi: 10.1007/BF00545964.
4
Dose-dependent pharmacokinetics with single daily dose slow release theophylline in patients with chronic lung disease.慢性肺病患者每日单次剂量缓释茶碱的剂量依赖性药代动力学。
Br J Clin Pharmacol. 1982 Feb;13(2):241-3. doi: 10.1111/j.1365-2125.1982.tb01368.x.
5
Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration.西咪替丁抑制慢性阻塞性肺疾病患者的茶碱清除率:一项在多次口服给药期间使用稳定同位素方法的研究。
Br J Clin Pharmacol. 1983 Apr;15(4):411-8. doi: 10.1111/j.1365-2125.1983.tb01523.x.
6
Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.茶碱普通无包衣剂型和缓释剂型的生物利用度及药代动力学与吸烟习惯的关系。I. 单剂量研究。
Eur J Clin Pharmacol. 1983;24(1):79-87. doi: 10.1007/BF00613931.
7
Lack of effect of short-term passive smoking on the metabolic disposition of theophylline.
Eur J Clin Pharmacol. 1990;39(4):399-402. doi: 10.1007/BF00315418.
8
Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
Eur J Clin Pharmacol. 1979;16(6):417-21. doi: 10.1007/BF00568203.
9
Hypothesis for the individualisation of drug dosage.药物剂量个体化的假设。
Clin Pharmacokinet. 1979 Nov-Dec;4(6):460-9. doi: 10.2165/00003088-197904060-00005.